Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Qualcomm (QCOM) reported $38.6B revenue in FY2024 (ended Sep), up 9% YoY. Snapdragon X Elite for on-device AI. Market cap ~$190B. 51,000+ employees. San Diego, CA. Licensing + chip sales model.
Qualcomm is the world's leading designer of mobile processors and wireless technology. The company's Snapdragon chips power the majority of Android smartphones globally, and its patent portfolio covering 3G/4G/5G wireless standards generates billions in licensing revenue.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.